Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thunder Bridge Acquisition II was a SPAC that completed its business combination with indie Semiconductor on June 10, 2021. The combined company retained the indie Semiconductor name and began trading on Nasdaq under the ticker symbols "INDI" and "INDIW". The transaction resulted in gross proceeds of approximately $400 million to indie Semiconductor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thunder Bridge Capital Acquisition II.